Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (241-250 of 279) with videos related to

Pageof 28
Sort By:
Neurology|September 16, 2018
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Guoqiao Wang, Brian A Gordon, et al.
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Annals of Neurology|March 27, 2016
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer networkSeonjoo Lee, Fawad Viqar, Molly E Zimmerman, et al.
Nature|September 30, 2017
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathyYang Shi, Kaoru Yamada, Shane Antony Liddelow, et al.
Plos One|May 10, 2018
White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's diseaseSeonjoo Lee, Molly E Zimmerman, Atul Narkhede, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 30, 2013
CSF biomarker variability in the Alzheimer's Association quality control programNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
Brain Connectivity|January 12, 2021
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer DiseaseRobert X Smith, Jeremy F Strain, Aaron Tanenbaum, et al.
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
The Lancet. Neurology|July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional studyAnne M Fagan, Rachel L Henson, Yan Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 28, 2022
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognitionPratishtha Chatterjee, Lisa Vermunt, Brian A Gordon, et al.
Pageof 28

Showing results (241-250 of 279) with videos related to

Sort By:
Pageof 28
Neurology|September 16, 2018
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Guoqiao Wang, Brian A Gordon, et al.
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Annals of Neurology|March 27, 2016
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer networkSeonjoo Lee, Fawad Viqar, Molly E Zimmerman, et al.
Nature|September 30, 2017
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathyYang Shi, Kaoru Yamada, Shane Antony Liddelow, et al.
Plos One|May 10, 2018
White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's diseaseSeonjoo Lee, Molly E Zimmerman, Atul Narkhede, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 30, 2013
CSF biomarker variability in the Alzheimer's Association quality control programNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
Brain Connectivity|January 12, 2021
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer DiseaseRobert X Smith, Jeremy F Strain, Aaron Tanenbaum, et al.
Nature Medicine|March 13, 2020
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's diseaseNicolas R Barthélemy, Yan Li, Nelly Joseph-Mathurin, et al.
The Lancet. Neurology|July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional studyAnne M Fagan, Rachel L Henson, Yan Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 28, 2022
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognitionPratishtha Chatterjee, Lisa Vermunt, Brian A Gordon, et al.
Pageof 28